Soluble HLA class I antigens in plasma of patients with malignant melanoma

Anticancer Research

Volumn 18, Issue 5 B, 1998, Pages 3789-3792

  Westhoff, Ulrike ^a,b   Fox, Claudia ^a   Otto, Friedrich J ^a  

^a Fachklinik Hornheide ^*  (Germany)

^b Fachklinik Hornheide   (Germany)

Author keywords

EDTA plasma; ELISA; Malignant melanoma; ROC analysis; Soluble HLA class I

Indexed keywords

HLA ANTIGEN CLASS 1; MEMBRANE ANTIGEN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031701902     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Zinkernagel RM, Doherty PC: Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogenic system. Nature 248: 701-702, 1974.
2. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DS. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512, 1987.
3. Brasseur F, Rimoldi D, Lienard D, Lethé B, Carrel S, Arienti F, Suter L et al: Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 63: 375-380, 1995.
4. van Duinen SG, Ruiter DJ, Broecker EB, van der Velde EA, Sorg C, Welcaart K, Ferrone S: Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res 48: 1019-1025, 1988.
5. Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S, Ferrone S: Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res 53: 3349-3354, 1993.
6. Ferrone S, Marincola FM: Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol today 16: 487-494, 1995.
7. Klar D, Hämmerling GJ: Induction of assembly of MHC class I heavy chains with ß2-microglobulin by interferon-γ. EMBO 8: 475-481, 1989.
8. Restifo NP, Esquivel F, Kawakami Y, Yewdell JW, Mule JJ, Rosenberg SA, Bennink JR: Identificaion of human cancers deficient in antigen processing. J Exp Med 177: 265-272, 1993.
9. Kao KJ: Plasma and platelet HLA in normal individuals: Quantitation by competitve enzyme-linked immunoassay. Blood 70: 282-286, 1987.
10. Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizu M, Grosse-Wilde H: Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992. Tissue Antigens 42: 45-54, 1993.
11. Krangel MS: Secretion of HLA-A and -B antiens via an alternative RNA splicing pathway. J Exp Med 163: 1173-1190, 1986.
12. Buelow R, Burlingham WJ, Clayberger C: Immunomodulation by soluble HLA class I. Transplantation 59: 649-654, 1995.
13. Puppo F, Scudeletti M, Indiveri F, Ferrone S: Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 16: 124-127, 1995.
14. Ferreira A, Villar ML, Alvarez-Cermeño JC, Revilla Y, Carcia Rodriguez MC, Fontan G, Gonzalez-Porque P: Quantification of soluble serum HA class I antigens in healthy volunteers and AIDS patients. Clin Chim Act 174: 207-212, 1988.
15. Alvarez-Cermeno JC, Brieva JA, Villar LM, Roldan E, Bootello A, Gonzalez-Porque P: Soluble HLA class I antigen secretion by peripheral blood lymphocytes in multiple sclerosis. Eur Neurol 33: 229-231, 1993.
16. Tsuji K, Kusama M, Nakatsuji T, Kato S: Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation. Tokai J Exp Clin Med 10: 169-174, 1985.
17. Westhoff U, Doxiadis I, Beelen DW, Schaefer UW, Grosse-Wilde H: Soluble HLA class I concentrations and GVHD allogeneic marrow transplantation. Transplantation 48: 891-893, 1989.
18. Zavazava N, Leimenstoll G, Muller-Ruchholtz W: Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor. J Clin Lab Anal 4: 426-429, 1990.
19. Tilg H, Westhoff U, Vogel W, Aulitzky WE, Herold M, Margreiter R Huber C, Grosse-Wilde H: Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol 14: 417-419, 1992.
20. Adamashvilli IM, McDonald JC, Fraser PA, Milford EL, Pressly TA, Gelder FB: Soluble class I HLA antigens in patients with rheumatoid arthritis and their families. J Rheumatol 22: 1025-1031, 1995.
21. Aulitzky WE, Grosse-Wilde H, Westhoff U, Tilg H, Aulitzky W, Gastl G, Herold M, Huber C: Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon gamma. Clin Exp Immunol 86: 236-239, 1991.
22. Hillebrand K, Moritz T, Westhoff U, Niederle N, Grosse-Wilde H: Soluble HLA class I and beta-2-microglobulin plasma concentrations during interferon treatment of chronic myelogenous leukemia. Vox Sang 67: 310-314, 1994.
23. Westhoff U, Manz, T, Otto FJ: Study of the distribution pattern of soluble HLA class I heavy chains in CML patients under IFN therapy using SDS-PAGE followed by Western blot. Fund Clin Immunol 4: 95-102, 1996.
24. Zavazava N, Kronke M: Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 2: 1005-1010, 1996.
25. Westhoff U, Grosse-Wilde H: Soluble HLA class I and class II concentrations in factor VIII and PCC Preparations. Vox Sang 68: 73-76, 1995.
26. Parham P, Barnstable CJ, Bodmer WF: Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J Immunol 123: 229-235, 1979.
27. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiol 143: 29-36, 1982.
28. Doxiadis I, Westhoff U, Grosse-Wilde H: Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 59: 449-454, 1989.
29. Kao KJ, Scornik JC, Riley WJ, McQueen CF: Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol 21: 115-124, 1988.
30. Zastava N, Hausmann R, Mueller-Ruchholtz W: Inhibition of anti-HLA-B7 alloreactive CTLs by affinity purified soluble HLA. Transplantation 57: 838-842, 1991.
31. Fan QOR, Garboczi DN, Winter CC, Wagtmann N, Long EO, Wiley DC: Direct binding of a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc Natl Acad Sci USA 93: 7178-7183, 1996.
32. Turowski G, Goscinski I, Gieracka D, Kedzierska A, Pawlowska E, Danilewicz B: Soluble HLA class I antigens in serum of patients with brain tumors. Pol Merkuriusz Lek 1: 410-411, 1996.
33. Pickl WF, Majdic O, Fae I, Reuschel R, Holter W, Knapp W: The soluble pool of ß2-microglobulin free HLA class I α-chains. J Imunol 151: 2613-2622, 1993.